title: 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
abstract: When assayed for specific opiate binding in the presence of 120 mM NaCl, digitonin extracts from frog (Rana ridibunda) brain membranes were found to contain about the same quantity (0.5 pmol/mg of protein) of high (Kdh = 0.4 nM) and of lower (Kdl = 15-20 nM) affinity sites for the opiate agonist [3H]etorphine. The two classes of [3H]etorphine binding sites displayed equally high (Kd = 0.3 nM) affinity for the opiate antagonist [3H]diprenorphine. 5'-Guanylylimidodiphosphate (GppNHp) selectively and potently (IC50 = 0.1 microM) inhibited high affinity binding of the tritiated agonist, and this inhibition resulted from the GppNHp-induced conversion of the high into the lower affinity sites for [3H]etorphine. Following centrifugation of the digitonin extract in sucrose gradients, opioid binding activity was found to be associated with two clearly separated macromolecular components of apparent sedimentation coefficients 11.5 and 9.7 S, respectively. The two components bound [3H]diprenorphine equally well, whereas the fast sedimented component bound [3H]etorphine better than did the slower sedimented one. In addition, labeling of the component of bigger apparent size with [3H]etorphine was considerably reduced in the presence of 50 microM GppNHp. Finally, in soluble extracts which had been (i) preincubated with and (ii) centrifuged in the presence of GppNHp, the fast sedimented component was no longer observed while there was about twice as much of the component of smaller apparent size as in control (no GppNHp) extracts. Together, these results demonstrated the existence of an opioid receptor-G protein complex which, in digitonin solution, was still amenable to regulation (dissociation) by guanine nucleotides.
authors.affiliation: Unité de Neuropharmacologie Moléculaire, Centre National de la Recherche Scientifique, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Mollereau
authors.forename: A
authors.initials: A
authors.lastname: Pascaud
authors.forename: G
authors.initials: G
authors.lastname: Baillat
authors.forename: H
authors.initials: H
authors.lastname: Mazarguil
authors.forename: A
authors.initials: A
authors.lastname: Puget
authors.forename: J C
authors.initials: JC
authors.lastname: Meunier
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D004072:Digitonin; D004174:Diprenorphine / Q000378:metabolism; D005048:Etorphine / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives*; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology*; D007700:Kinetics; D008970:Molecular Weight; D011895:Rana ridibunda; D011957:Receptors, Opioid / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*
chemical_list: D011957:Receptors, Opioid; D004174:Diprenorphine; D006165:Guanylyl Imidodiphosphate; D005048:Etorphine; D006160:Guanosine Triphosphate; D004072:Digitonin